Ulcers are chronic wounds that can develop on both the interior and superficial surfaces of the body. These are often caused by infections by various microorganisms, poor blood circulation, and underlying health conditions. Bacterial biofilms play a significant role in contributing to the delay of the healing process and create a protective barrier around pathogens, making them highly resistant to classical antibiotics and immune responses. The presence of biofilms in ulcers leads to prolonged infections, persistent inflammation, and increased challenges in the treatment strategies, necessitating the use of advanced therapeutic strategies. Prevention is the most important aspect of ulcer management by the use of action plans that include maintaining self-hygiene, managing blood sugar levels in diabetic patients, using compression therapies for venous leg ulcers, and decreasing prolonged pressure on various body parts or on the skin to prevent bedsores. Preliminary diagnosis and multimodal treatment approaches that include antibiotics, wound debridement (cleaning of wounds), and specialized dressings are vital for effective healing. Contemporary advancements in herbal medicines and their use by integrating them with nanotechnologies offer promising anti-biofilm and regenerative therapies for ulcers. Herbal compounds that contain biofilm-disrupting properties are emerging as natural and safer alternatives to conventional antibiotics. Drug delivery systems that are based on nanomedicines enhance the penetration of antimicrobial agents into the biofilms, thereby increasing the treatment efficacy. The amalgamation of nanotechnology, bioengineered skin grafts, and personalized medicine led to a huge shift in ulcer management regimes. These also offered faster healing techniques, reduced resistance to antibiotics, and improved patient outcomes. Continued innovations and research in biofilm-targeted therapies will pave the way for more patient-friendly, effective, and sustainable solutions for ulcer treatment in the future.